• When preparing to initiate your first virtual event, whether it be a commercial or medical affairs advisory board, a clinical steering committee or even a patient advocacy session, following standard best practices can greatly increase your business results.

    Read More

  • Pharmaceutical companies are looking for convenient, cost-effective ways to engage physicians, patients, payers, and other external stakeholders throughout the drug development lifecycle. Online discussion technologies have been praised by teams and external stakeholders alike for being efficient and effective.  When first considering online discussion technologies, however, companies often have initial compliance concerns.

    Read More

  • For the health and life science industry, budgetary planning is no easy feat. What has worked in years past might not work in the future. However, as the healthcare industry continues (and will continue) to evolve, some things will remain the same. The speakers bureau has been a longtime tactic in a healthcare marketing plan. While it may have seen a decline in usage over the years, the speakers bureau has evolved and will remain instrumental in healthcare providers’ research and ongoing education.

    Read More

  • Clinical trials are key to developing new methods to detect, treat and prevent diseases. Researchers use these trials to determine whether treatments are safe, effective and better than current therapies. Genomic testing in clinical trials can help bring genome-targeted medicines to patients quicker than ever before. This method promises to tailor treatments to an individual’s disease and molecular make-up rather than through the trial-and-error process. The following article defines genomic testing and how it is currently used in clinical trials.

    Read More

  • Compared to what was available only ten short years ago, today’s range of digital collaboration and communication options is astounding. Read more about how innovators are weaving digital solutions into the everyday fabric of their communications.

    Read More

  • Life sciences continues to be an ever-evolving industry. And 2016 is no exception. From shifting focus to a value-based care model to rising healthcare costs to stricter regulations, the health and life sciences industry has certainly seen its share of changes this year.

    Read More

  • Collecting valuable data from clinical trials in paper form can be time-intensive, expensive and challenging. Electronic data capture (EDC) is a way to receive high quality clinical trial data while cutting costs and gaining a greater degree of security. However, according to research, only about half of regulated studies use EDC. This might be due to lack of knowledge or simply resistance to change. Whatever the reason, it is important to understand the advantages of EDC and how it is improving clinical trial studies. The following article offers 5 benefits of electronic data capture in clinical trial studies.

    Read More

  • In pharma, speakers bureaus are used for accelerating awareness and clinical expertise of important new treatments. Doctors and other HCPs use real-world clinical experience to educate and inform peers of different therapies for a particular disease. But, launching a speakers bureau is more than creating a PowerPoint presentation, contracting a speaker and inviting healthcare professionals to listen to your program.

    Read More

  • When marketing in the pharmaceutical industry, you have to have a goal in mind. For years, it has always been financially focused. But, as the world of marketing has been reinventing itself, so, too, should its success metrics. Return on engagement could be the new guide to success. But, what does that mean exactly?

    Read More

  • Organizations that successfully innovate can produce miraculous interventions, technologies and therapies. Pharmaceutical companies are constantly tasked with being innovative, while reducing time and cost to market therapies. Innovation is about continuous process improvement; so, how can the industry effectively manage innovation?

    Read More

  • KOLs play a vital role in the health and life sciences industry. But with more and more hurdles, engaging them has become more difficult. Because of this, pharma companies must better understand KOLs and their motivators in order to provide new and better ways to gain their participation.

    Read More

  • 3D printing has been around for years, mainly used in manufacturing. In more recent years, it has expanded into healthcare, where it’s been used to create custom prosthetics and dental implants. But, with the advent of the first FDA-approved 3D printed drug, this approach is expanding, allowing for more personalized healthcare at a lower cost.

    Read More

  • According to research, among the top 50 pharmaceutical companies worldwide, only about half of them actively participate on social media. On the other hand, 78% of Americans use social media and use it to get and information about health. So, why isn’t the pharma industry employing more social media to engage these consumers? While regulatory hurdles have stalled social media adoption in the past, now is the time to seize the opportunity.

    Read More

  • The term “biomarker” refers to a measure of a biological state. Biomarkers are used to perform a clinical assessment, such as blood pressure, to monitor and predict health states in individuals. Biomarker-enabled research & development is maturing into a new methodology that allows drug makers to focus on patients with more precision.

    Read More

  • In a rapidly shifting healthcare environment, payers now sit at the epicenter, increasingly encouraged to make decisions about which drugs and treatments are prescribed. Their growing influence explains why previous marketing initiatives no longer get the best results. Market success now depends on the ability to reach and persuade payers.

    Read More

  • Therapeutic substitution, while widely utilized, comes with its own set of obstacles. Although these substitutions may decrease costs for institutions and payers, it may create time-related costs for physicians and their patients. In the following article, we discuss the effect of therapeutic substitutions as a common practice in the healthcare industry.

    Read More